TT1 Products, LLC

TT1 Products, LLC, doing business as Supersapiens, specializes in innovative continuous glucose monitoring solutions, empowering consumers to optimize metabolic health through real-time glucose data. Founded in 2019 in Atlanta, US, Supersapiens focuses on continuous glucose monitoring solutions. The company was established by Fitzalan Crowe, Jay Robbins, Phil Southerland, and Todd Furneaux. Phil Southerland serves as CEO.

In April 2021, Supersapiens raised USD 13. 5 mn in a funding round led by MICA Ventures AG, with participation from other investors, and has raised a total of USD 13. 5 mn. Supersapiens specializes in providing innovative continuous glucose monitoring (CGM) solutions designed to enhance metabolic efficiency and overall health for athletes and health-conscious consumers.

Their core product is a personal CGM system that offers real-time glucose data through a Bluetooth-connected sensor, allowing users to monitor their glucose levels without the need for a smartphone. This product is particularly valuable for athletes, as it helps them optimize their nutrition and fueling strategies during training and events. The company targets a diverse client base, including triathletes, marathon runners, and casual fitness enthusiasts, primarily across markets in North America, Europe, and Australia. By offering seamless integration with popular health and fitness apps, Supersapiens aims to empower users to improve their performance, recovery, and body composition through precise glucose management.

Supersapiens generates revenue primarily through direct-to-consumer subscriptions for their CGM services. Clients typically engage with the company by subscribing to plans that include a set number of sensors and access to their proprietary app, which provides detailed insights into glucose levels and related metrics. The subscription model facilitates recurring revenue, allowing users to receive continuous support and updates as they monitor their metabolic health. Specific pricing plans are structured to offer different tiers based on the duration and quantity of sensors included, catering to both casual users and professional athletes who require ongoing data for performance optimization.

This business model not only ensures a steady stream of income but also fosters a community of users who rely on Supersapiens' technology to enhance their athletic performance and overall well-being. Supersapiens intends to leverage the recent funding of USD 13. 5 mn raised in April 2021 to further develop their continuous glucose monitoring technology and expand their product offerings. The company is focused on launching new innovative products aimed at enhancing user experience and accuracy in glucose monitoring.

Additionally, Supersapiens plans to enter new geographic markets, particularly targeting expansion into Europe and Australia by late 2023. The recent funding will support these initiatives, enabling the company to enhance its research and development capabilities and increase marketing efforts to reach new customers.